262 related articles for article (PubMed ID: 25088469)
1. Clinicopathologic outcomes of cystic renal cell carcinoma.
Donin NM; Mohan S; Pham H; Chandarana H; Doshi A; Deng FM; Stifelman MD; Taneja SS; Huang WC
Clin Genitourin Cancer; 2015 Feb; 13(1):67-70. PubMed ID: 25088469
[TBL] [Abstract][Full Text] [Related]
2. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
[TBL] [Abstract][Full Text] [Related]
3. Bosniak category IIF and III cystic renal lesions: outcomes and associations.
Smith AD; Remer EM; Cox KL; Lieber ML; Allen BC; Shah SN; Herts BR
Radiology; 2012 Jan; 262(1):152-60. PubMed ID: 22106359
[TBL] [Abstract][Full Text] [Related]
4. Utility of frozen section analysis of resection margins during partial nephrectomy.
Kubinski DJ; Clark PE; Assimos DG; Hall MC
Urology; 2004 Jul; 64(1):31-4. PubMed ID: 15245928
[TBL] [Abstract][Full Text] [Related]
5. Malignancy Rate, Histologic Grade, and Progression of Bosniak Category III and IV Complex Renal Cystic Lesions.
Mousessian PN; Yamauchi FI; Mussi TC; Baroni RH
AJR Am J Roentgenol; 2017 Dec; 209(6):1285-1290. PubMed ID: 28981360
[TBL] [Abstract][Full Text] [Related]
6. Preoperative decision making for renal cell carcinoma: cystic morphology in cross-sectional imaging might predict lower malignant potential.
Huber J; Winkler A; Jakobi H; Bruckner T; Roth W; Hallscheidt P; Daneshvar K; Hohenfellner M; Pahernik S
Urol Oncol; 2014 Jan; 32(1):37.e1-6. PubMed ID: 23587431
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic partial nephrectomy for cystic masses.
Spaliviero M; Herts BR; Magi-Galluzzi C; Xu M; Desai MM; Kaouk JH; Tucker K; Steinberg AP; Gill IS
J Urol; 2005 Aug; 174(2):614-9. PubMed ID: 16006923
[TBL] [Abstract][Full Text] [Related]
8. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
[TBL] [Abstract][Full Text] [Related]
9. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
10. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
11. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
12. Cystic renal cell carcinomas: do they grow, metastasize, or recur?
Jhaveri K; Gupta P; Elmi A; Flor L; Moshonov H; Evans A; Jewett M
AJR Am J Roentgenol; 2013 Aug; 201(2):W292-6. PubMed ID: 23883243
[TBL] [Abstract][Full Text] [Related]
13. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
Honda Y; Goto K; Nakamura Y; Terada H; Sentani K; Yasui W; Sekino Y; Hayashi T; Teishima J; Matsubara A; Fuji T; Kaichi Y; Higaki T; Baba Y; Iida M; Awai K
Abdom Radiol (NY); 2017 Jul; 42(7):1850-1856. PubMed ID: 28534069
[TBL] [Abstract][Full Text] [Related]
14. Progression, interobserver agreement, and malignancy rate in complex renal cysts ( ≥ Bosniak category IIF).
El-Mokadem I; Budak M; Pillai S; Lang S; Doull R; Goodman C; Nabi G
Urol Oncol; 2014 Jan; 32(1):24.e21-7. PubMed ID: 23395236
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors.
Pierorazio PM; Hyams ES; Lin BM; Mullins JK; Allaf ME
Urology; 2012 Mar; 79(3):570-5. PubMed ID: 22386399
[TBL] [Abstract][Full Text] [Related]
16. Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification.
Boissier R; Ouzaid I; Nouhaud FX; Khene Z; Dariane C; Chkir S; Chelly S; Giwerc A; Allenet C; Lefrancq JB; Gimel P; Bodin T; Rioux-Leclercq N; Correas JM; Albiges L; Hetet JF; Bigot P; Bernhard JC; Long JA; Mejean A; Bensalah K;
Int Urol Nephrol; 2019 Jun; 51(6):951-958. PubMed ID: 30977021
[TBL] [Abstract][Full Text] [Related]
17. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
[TBL] [Abstract][Full Text] [Related]
18. Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomography.
You D; Shim M; Jeong IG; Song C; Kim JK; Ro JY; Hong JH; Ahn H; Kim CS
BJU Int; 2011 Nov; 108(9):1444-9. PubMed ID: 21722289
[TBL] [Abstract][Full Text] [Related]
19. [The incidence of malignant transformation of renal cysts of category 1, 2, and 2F by the BOSNIAK classification into multilocular cystic renal cell carcinoma].
Darenkov SP; Proskokov AA; Agabekian AA; Trofimov IA
Urologiia; 2018 Jul; (3):111-115. PubMed ID: 30035429
[TBL] [Abstract][Full Text] [Related]
20. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
Doshi AM; Huang WC; Donin NM; Chandarana H
AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
